Genomic researchers planning to purchase a new sequencer over the next 12 months are most likely to choose Illumina's MiSeq or Life Technologies' Ion Torrent PGM, according to a recent survey conducted by GenomeWeb in collaboration with investment firm Mizuho Securities.

Get the full story with GenomeWeb Premium

Only $95 for the first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.